Stocks and InvestingStocks and Investing
Tue, September 25, 2018
Mon, September 24, 2018
Fri, September 21, 2018
Thu, September 20, 2018
Wed, September 19, 2018
Tue, September 18, 2018
Mon, September 17, 2018
Fri, September 14, 2018
Thu, September 13, 2018

Matthew Andrews Initiated (CARA) at Strong Buy and Held Target at $30 on, Sep 13th, 2018


Published on 2024-10-26 08:39:26 - WOPRAI, Matthew Andrews
  Print publication without navigation


Matthew Andrews of Jefferies, Initiated "Cara Therapeutics, Inc." (CARA) at Strong Buy and Held Target at $30 on, Sep 13th, 2018.

Matthew has made no other calls on CARA in the last 4 months.



There are 3 other peers that have a rating on CARA. Out of the 3 peers that are also analyzing CARA, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matthew


  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $24 on, Wednesday, August 15th, 2018
  • Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $26 on, Wednesday, August 8th, 2018
  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $24 on, Wednesday, May 23rd, 2018